Prof Eliza Hawkes
Honorary Professorial Fellow
Department of Medicine
326 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Diagnosis-to-treatment interval is associated with outcomes in follicular lymphoma treated with immunochemotherapy
DOI: 10.1182/blood.20260330902026
Journal article
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
DOI: 10.1200/JCO-26-009472026
Journal article
Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD, plus rituximab (R) versus investigator’s choice (IC) in patients (pts) with relapsed/refractory follicular lymphoma (R/R FL) who have received ≥ 1 line of systemic therapy: GOLSEEK-4, a phase (Ph) 3, randomized study.
DOI: 10.1200/jco.2026.44.16_suppl.tps71022026
Journal article
Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II ‘FLUORO’ study
DOI: 10.1111/bjh.704682026
Journal article
Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
DOI: 10.1182/bloodadvances.20260200122026
Journal article
Toxicity outcomes in phase 1 lymphoma trials abstracts are under-reported, with high use of minimizing language
DOI: 10.1002/hem3.703512026
Journal article
Body Mass Index and Clinical Associations in Australasian Lymphoma Patients: A Lymphoma and Related Diseases Registry Study
DOI: 10.1002/jha2.70212
RECENT SCHOLARLY WORKS
2026
Journal article
Older patients with lymphoma: navigating a landscape of clinical controversies and barriers to innovation.
DOI: 10.3324/haematol.2025.2887002026
Journal article
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma
DOI: 10.1200/JCO-25-008922026
Journal article
Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinion
DOI: 10.1080/10428194.2026.2640453